Forte Biosciences's total assets for Q1 2025 were $47.46M, a decrease of -22.91% from the previous quarter. FBRX total liabilities were $9.03M for the fiscal quarter, a -0.54% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.